• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中低收入国家哮喘和慢性阻塞性肺疾病负担及基本药物可及性。

Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries.

机构信息

Division of Tropical and Humanitarian Medicine, University Hospitals of Geneva and University of Geneva, Geneva, Switzerland.

Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa; MRC Unit on Child and Adolescent Lung Health, University of Cape Town, Cape Town, South Africa.

出版信息

Lancet Respir Med. 2015 Feb;3(2):159-170. doi: 10.1016/S2213-2600(15)00004-1.

DOI:10.1016/S2213-2600(15)00004-1
PMID:25680912
Abstract

Demographic and epidemiological transitions are changing the age structure of the population and the most common diseases. Non-communicable respiratory diseases are an increasing problem at both ends of the age range in low-income and middle-income countries. In children, who represent a large proportion of the total population, the increasing problem of asthma is a strain on health services. Improved survival of the older population is increasing the proportion of morbidity and mortality attributable to chronic lung diseases. Health services in low-resource countries are poorly adapted to treating chronic diseases. Designed to respond episodically to acute disease, almost all historical investment has focused on infectious diseases. Crucial to the successful management of chronic diseases is an infrastructure designed to support pro-active management, providing not only an accurate diagnosis, but also a secure supply of cost effective drugs at an affordable price. The absence of such an infrastructure in many countries and the market failure that makes drugs generally more expensive in low-resource regions means that many people with chronic non-communicable lung diseases are not given effective treatment. This has damaging economic consequences. The common causes of poor lung health in low-income countries are not the same as those in richer countries, and there is a need to study why they are so common and how best to manage them.

摘要

人口结构和流行病学的转变正在改变人口的年龄结构和最常见的疾病。在中低收入国家,非传染性呼吸系统疾病在年龄范围的两端都是一个日益严重的问题。在儿童中,他们占总人口的很大比例,哮喘问题的日益严重给卫生服务带来了压力。老年人口的存活率提高,使慢性病导致的发病率和死亡率比例增加。资源匮乏国家的卫生服务机构对慢性病的治疗适应能力很差。卫生服务机构的设计目的是应对急性疾病,因此几乎所有历史投资都集中在传染病上。慢性病的成功管理取决于支持积极管理的基础设施,这不仅需要准确的诊断,还需要以负担得起的价格提供安全的、具有成本效益的药物供应。许多国家缺乏这样的基础设施,以及使药品在资源匮乏地区普遍更昂贵的市场失灵,意味着许多患有慢性非传染性肺部疾病的人没有得到有效的治疗。这会带来破坏性的经济后果。低收入国家肺部健康状况不佳的常见原因与较富裕国家的原因不同,因此需要研究为什么这些原因如此普遍,以及如何最好地管理这些原因。

相似文献

1
Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries.中低收入国家哮喘和慢性阻塞性肺疾病负担及基本药物可及性。
Lancet Respir Med. 2015 Feb;3(2):159-170. doi: 10.1016/S2213-2600(15)00004-1.
2
Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management.发展中国家的慢性呼吸道疾病:负担以及预防与管理策略
Bull World Health Organ. 2001;79(10):971-9. Epub 2001 Nov 1.
3
Essential medicines for COPD and asthma in low and middle-income countries.中低收入国家的 COPD 和哮喘基本药物。
Thorax. 2014 Dec;69(12):1149-51. doi: 10.1136/thoraxjnl-2014-205249. Epub 2014 Mar 3.
4
History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.慢性阻塞性肺疾病患者的哮喘病史。经济负担的比较研究。
Ann Am Thorac Soc. 2016 Feb;13(2):188-96. doi: 10.1513/AnnalsATS.201508-507OC.
5
The global economic burden of asthma and chronic obstructive pulmonary disease.哮喘和慢性阻塞性肺疾病的全球经济负担。
Int J Tuberc Lung Dis. 2016 Jan;20(1):11-23. doi: 10.5588/ijtld.15.0472.
6
Access to essential medicines to treat chronic respiratory disease in low-income countries.低收入国家获取治疗慢性呼吸道疾病的基本药物的情况。
Int J Tuberc Lung Dis. 2016 Jun;20(6):717-28. doi: 10.5588/ijtld.15.0734.
7
The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.1980年和1991年哮喘及慢性阻塞性肺疾病(COPD)在瑞典造成的经济影响。
Respir Med. 2000 Mar;94(3):247-55. doi: 10.1053/rmed.1999.0733.
8
Approaches to achieving equality in respiratory health.实现呼吸健康平等的方法。
Lancet Respir Med. 2015 Feb;3(2):97-98. doi: 10.1016/S2213-2600(14)70247-4. Epub 2014 Nov 12.
9
COPD management. Part II. Relevance for resource-poor settings.慢性阻塞性肺疾病的管理。第二部分。对资源匮乏地区的意义。
Int J Tuberc Lung Dis. 2008 Jun;12(6):595-600.
10
Economic burden of expected epidemiological changes in diseases related to tobacco, Mexico.墨西哥与烟草相关疾病预期流行病学变化的经济负担
Rev Saude Publica. 2007 Aug;41(4):523-9. doi: 10.1590/s0034-89102006005000033.

引用本文的文献

1
Chronic Respiratory Disease Prevalence, Burden, and Treatment in Cape Town: A Cross-Sectional Study.开普敦慢性呼吸道疾病的患病率、负担及治疗情况:一项横断面研究。
Health Sci Rep. 2025 Jul 9;8(7):e70992. doi: 10.1002/hsr2.70992. eCollection 2025 Jul.
2
Association between frailty and frailty change with chronic lung disease: results from two prospective cohort studies.衰弱与慢性肺病导致的衰弱变化之间的关联:两项前瞻性队列研究的结果
BMC Public Health. 2025 Jul 2;25(1):2283. doi: 10.1186/s12889-025-22601-x.
3
Genetic prediction of immune cells, inflammatory proteins, and metabolite-mediated association between gut microbiota and COPD: a Mendelian randomization study.
免疫细胞、炎症蛋白以及肠道微生物群与慢性阻塞性肺疾病之间代谢物介导关联的遗传预测:一项孟德尔随机化研究
Sci Rep. 2025 Jul 1;15(1):21633. doi: 10.1038/s41598-025-05290-9.
4
Leptin and Insulin in COPD: Unveiling the Metabolic-Inflammatory Axis-A Narrative Review.慢性阻塞性肺疾病中的瘦素与胰岛素:揭示代谢-炎症轴——一篇叙述性综述
J Clin Med. 2025 Apr 10;14(8):2611. doi: 10.3390/jcm14082611.
5
Epidemiological trends and risk factors of chronic obstructive pulmonary disease in young individuals based on the 2021 global burden of disease data (1990-2021).基于2021年全球疾病负担数据(1990 - 2021年)的年轻个体慢性阻塞性肺疾病的流行病学趋势及危险因素
BMC Pulm Med. 2025 Apr 12;25(1):174. doi: 10.1186/s12890-025-03630-z.
6
Exploring the association between socioeconomic inequalities in chronic respiratory disease and all-cause mortality in China: findings from the China Health and Retirement Longitudinal Study.探索中国慢性呼吸道疾病的社会经济不平等与全因死亡率之间的关联:来自中国健康与养老追踪调查的发现
Front Public Health. 2025 Jan 7;12:1472074. doi: 10.3389/fpubh.2024.1472074. eCollection 2024.
7
A cross-tissue transcriptome-wide association study reveals GRK4 as a novel susceptibility gene for COPD.一项跨组织转录组全基因组关联研究揭示 GRK4 是 COPD 的一个新的易感基因。
Sci Rep. 2024 Nov 18;14(1):28438. doi: 10.1038/s41598-024-80122-w.
8
Impact of pharmacist-led intervention in medication adherence and inhaler usage on asthma and chronic obstructive pulmonary disease control: a quasi-experimental study.药剂师主导的干预对药物依从性和吸入器使用对哮喘和慢性阻塞性肺疾病控制的影响:一项准实验研究。
BMC Health Serv Res. 2024 Oct 8;24(1):1199. doi: 10.1186/s12913-024-11683-9.
9
WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD.WISP1 和巨噬细胞移动抑制因子在呼吸道炎症中的作用:哮喘和 COPD 的新见解和治疗潜力。
Int J Mol Sci. 2024 Sep 18;25(18):10049. doi: 10.3390/ijms251810049.
10
Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study.使用吸入性皮质类固醇患者的骨折风险升高:一项韩国全国性研究。
Endocrinol Metab (Seoul). 2025 Feb;40(1):82-92. doi: 10.3803/EnM.2024.1990. Epub 2024 Aug 30.